{
  "id": "d435fef6201fb087",
  "title": "Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis",
  "description": "20260217T223000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/02/17/1537358/long-term-data-published-in-jama-neurology-demonstrate-sustained-efficacy-and-consistent-safety-of-briumvi-in-relapsing-multiple-sclerosis/",
  "published_at": "20260217T223000Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/02/17/1537358/long-term-data-published-in-jama-neurology-demonstrate-sustained-efficacy-and-consistent-safety-of-briumvi-in-relapsing-multiple-sclerosis/",
    "url_mobile": "",
    "title": "Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis",
    "seendate": "20260217T223000Z",
    "socialimage": "https://ml.globenewswire.com/media/ZTE0MDg2NWItYTQ1MC00NjQwLTljMzEtMmU1ZjdlZGY3ZDM3LTEwMzIxMzAtMjAyNi0wMi0xNy1lbg==/tiny/TG-Therapeutics-Inc-.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}